These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25441987)

  • 1. Monitoring of prostate cancer growth and metastasis using a PSA luciferase report plasmid in a mouse model.
    Mao QQ; Lin YW; Chen H; Yang K; Kong DB; Jiang H
    Asian Pac J Trop Med; 2014 Nov; 7(11):879-83. PubMed ID: 25441987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
    Scatena CD; Hepner MA; Oei YA; Dusich JM; Yu SF; Purchio T; Contag PR; Jenkins DE
    Prostate; 2004 May; 59(3):292-303. PubMed ID: 15042605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple metastases in a novel LNCaP model of human prostate cancer.
    Zou M; Jiao J; Zou Q; Xu Y; Cheng M; Xu J; Zhang Y
    Oncol Rep; 2013 Aug; 30(2):615-22. PubMed ID: 23446457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring luciferase-labeled human prostate stem cell antigen-expressing tumor growth in a mouse model.
    Dong L; Zhang X; Yu C; Yu T; Liu S; Hou L; Fu L; Yi S; Chen W
    Exp Ther Med; 2013 Nov; 6(5):1208-1212. PubMed ID: 24223645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.
    Wang D; Wang Z; Tian J; He X; Chowdhury WH; Zhang X; Li S; Rodriguez R
    Urol Oncol; 2010; 28(2):164-9. PubMed ID: 18440837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
    Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP
    Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of a human bladder cancer cell line stably co-expressing hSPRY2 and luciferase genes and its subcutaneous tumor xenograft model in nude mice].
    Yin X; Li F; Jin Y; Yin Z; Qi S; Wu S; Wang Z; Wang L; Yu J; Gao J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):337-341. PubMed ID: 28274312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of a pulmonary metastasis model of melanoma with stably expressed hTERT/Luc].
    Xiao Y; Gao J; Gao K; Yan J; Zhang L; Wang Y; Xu Y; Wang X; Yu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):89-92. PubMed ID: 23294724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells].
    Deng F; Wang CX; Xu WF; Feng L; Ke ZY; Wang QJ; Zou ZP
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1779-82. PubMed ID: 20813663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and application of the replicon DNA recombinant plasmid pSVK-luc].
    Li P; Zhang L; Wang Y; Zhu X; Zhang W; Xu Y; Yu J; Yan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):765-8. PubMed ID: 23837991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive imaging of firefly luciferase reporter gene expression using bioluminescence imaging in human prostate cancer models.
    Li H; Li JZ; Helm GA; Pan D
    Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):179-84. PubMed ID: 17073822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml.
    Catalona WJ; Bartsch G; Rittenhouse HG; Evans CL; Linton HJ; Amirkhan A; Horninger W; Klocker H; Mikolajczyk SD
    J Urol; 2003 Dec; 170(6 Pt 1):2181-5. PubMed ID: 14634374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Establishment and Identification of Acute Myeloid Leukemia NOD-SCID-IL2rg
    Zhang WY; Zeng GC; Chen XM; Geng SX; Wang YL; Luo Q; Luo LP; Lai PL; Weng JY; DU X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1429-1435. PubMed ID: 34627421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and identification of recombinant firefly luciferase reporter plasmid pGL2-PEPCK-Luc].
    Feng K; Wang H; Sun Q; Xiao XH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):562-5. PubMed ID: 15562773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
    Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
    Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.
    Mikolajczyk SD; Marker KM; Millar LS; Kumar A; Saedi MS; Payne JK; Evans CL; Gasior CL; Linton HJ; Carpenter P; Rittenhouse HG
    Cancer Res; 2001 Sep; 61(18):6958-63. PubMed ID: 11559576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.
    Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Marks LS; Song W; Wheeler TM; Slawin KM
    Cancer Res; 2000 Feb; 60(3):756-9. PubMed ID: 10676664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.